1. Home
  2. UVE vs TRVI Comparison

UVE vs TRVI Comparison

Compare UVE & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UVE
  • TRVI
  • Stock Information
  • Founded
  • UVE 1990
  • TRVI 2011
  • Country
  • UVE United States
  • TRVI United States
  • Employees
  • UVE N/A
  • TRVI N/A
  • Industry
  • UVE Property-Casualty Insurers
  • TRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • UVE Finance
  • TRVI Health Care
  • Exchange
  • UVE Nasdaq
  • TRVI Nasdaq
  • Market Cap
  • UVE 666.1M
  • TRVI 725.7M
  • IPO Year
  • UVE 1992
  • TRVI 2019
  • Fundamental
  • Price
  • UVE $24.63
  • TRVI $7.96
  • Analyst Decision
  • UVE
  • TRVI Strong Buy
  • Analyst Count
  • UVE 0
  • TRVI 9
  • Target Price
  • UVE N/A
  • TRVI $20.72
  • AVG Volume (30 Days)
  • UVE 132.1K
  • TRVI 2.9M
  • Earning Date
  • UVE 10-23-2025
  • TRVI 11-05-2025
  • Dividend Yield
  • UVE 3.03%
  • TRVI N/A
  • EPS Growth
  • UVE N/A
  • TRVI N/A
  • EPS
  • UVE 2.28
  • TRVI N/A
  • Revenue
  • UVE $1,567,371,000.00
  • TRVI N/A
  • Revenue This Year
  • UVE $1.87
  • TRVI N/A
  • Revenue Next Year
  • UVE N/A
  • TRVI N/A
  • P/E Ratio
  • UVE $11.13
  • TRVI N/A
  • Revenue Growth
  • UVE 5.64
  • TRVI N/A
  • 52 Week Low
  • UVE $16.50
  • TRVI $2.36
  • 52 Week High
  • UVE $28.49
  • TRVI $9.92
  • Technical
  • Relative Strength Index (RSI)
  • UVE 50.16
  • TRVI 51.90
  • Support Level
  • UVE $24.13
  • TRVI N/A
  • Resistance Level
  • UVE $24.95
  • TRVI $9.92
  • Average True Range (ATR)
  • UVE 0.61
  • TRVI 0.73
  • MACD
  • UVE 0.04
  • TRVI -0.24
  • Stochastic Oscillator
  • UVE 34.21
  • TRVI 80.19

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: